1. Agostoni A, Aygoren-Pursun E, Binkley KE, Blanch A, Bork K, Bouillet L, et al. Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol 2004;114(3 Suppl):S51-131.

2. The European register of HAE patients. Presented at: Development of a Complex Communication System Between the Actors Involved into the Management of Rare Diseases. February 2008; Tirgu-Mures, Romania.

3. Frank M. Hereditary angioedema: the clinical syndrome and its management in the United States. Immunol Allergy Clin N Am 2006;26:653-68.

4. Gibbs J, Craig T. Poster 1087: prodromal symptoms before exacerbations of hereditary angioedema. J Allergy Clin Immunol 2007;119(Suppl 1):S278.

5. Weiler CR, van Dellen RG. Genetic test indications and interpretations in patients with hereditary angioedema. Mayo Clin Proc 2006;81(7):958-72.

6. Zingale LC, Bork K, Farkas H. Poster 1079: the European register of hereditary angioedema: experience and preliminary results. J Allergy Clin Immunol 2007;2007(Suppl 1):S276.

7. US Hereditary Angioedema Association. What is HAE?, 2011.

8. Roche O, Blanch A, Caballero T, Sastre N, Callejo D, Lopez-Trascasa M. Hereditary angioedema due to C1 inhibitor deficiency: patient registry and approach to the prevalence in Spain. Ann Allergy Asthma Immunol 2005;94(4):498-503.

9. Gompels MM, Lock RJ, Abinun M, Bethune CA, Davies G, Grattan C, et al. C1 inhibitor deficiency: consensus document. Clin Exp Immunol 2005;139(3):379-94.

10. Bowen T, Cicardi M, Bork K, Zuraw B, Frank M, Ritchie B, et al. Herediatry angioedema: a current state-of-the-art review, VII: Canadian Hungarian 2007 international consensus algorithm for the diagnosis, therapy, and management of hereditary angioedema. Ann Allergy Asthma Immunol 2008;100(Suppl 2):S30-S40.

11. CSL Behring. Berinert®, Summary of Product Characteristics. May 2011.

12. Davis AE, 3rd, Cai S, Liu D. C1 inhibitor: biologic activities that are independent of protease inhibition. Immunobiology 2007;212(4-5):313-23.

13. Caliezi C, Wuillemin WA, Zeerleder S, Redondo M, Eisele B, Hack CE. C1-Esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema. Pharmacol Rev 2000;52(1):91-112.

14. Bernstein JA, Ritchie B, Levy RJ, Wasserman RL, Bewtra AK, Hurewitz DS, et al. Population pharmacokinetics of plasma-derived C1 esterase inhibitor concentrate used to treat acute hereditary angioedema attacks. Ann Allergy Asthma Immunol 2010;105(2):149-54.

15. Martinez-Saguer I, Rusicke E, Aygoren-Pursun E, von Hentig N, Klingebiel T, Kreuz W. Pharmacokinetic analysis of human plasma-derived pasteurized C1-inhibitor concentrate in adults and children with hereditary angioedema: a prospective study. Transfusion 2010;50(2):354-60.

LinkedIn Twitter Facebook Google+